We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current WST market cap is 26.42B. The company's latest EPS is USD 8.0956 and P/E is 44.52.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 687.3M | 705.8M | 716.8M | 755.6M | 748.8M |
| Operating Income | 191.9M | 127.2M | 168.1M | 162.1M | 184.1M |
| Net Income | 120.6M | 103M | 140M | 155.1M | 161.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.85B | 2.15B | 2.83B | 2.89B | 2.95B |
| Operating Income | 297.6M | 405.4M | 750.9M | 728.4M | 702.6M |
| Net Income | 241.7M | 346.2M | 661.8M | 585.9M | 593.4M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.32B | 3.62B | 3.72B | 3.67B | 3.75B |
| Total Liabilities | 846M | 931.9M | 947.4M | 922.9M | 886.5M |
| Total Equity | 2.47B | 2.68B | 2.78B | 2.75B | 2.87B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.34B | 2.79B | 3.31B | 3.62B | 3.83B |
| Total Liabilities | 768.2M | 939.3M | 978.4M | 931.9M | 948.5M |
| Total Equity | 1.57B | 1.85B | 2.34B | 2.68B | 2.88B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 493.2M | 724M | 138.1M | 307.3M | 537.4M |
| Investing | -193.4M | -288.2M | -82.1M | -164.2M | -259.9M |
| Financing | -284.1M | -293.6M | -71M | -247.8M | -270.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 367.2M | 472.5M | 584M | 724M | 776.5M |
| Investing | -228M | -179.5M | -253.1M | -288.2M | -368.7M |
| Financing | -36.8M | -137.1M | -168.1M | -293.6M | -459.6M |
| Market Cap | 26.42B |
| Price to Earnings Ratio | 44.52 |
| Price to Sales Ratio | 8.95 |
| Price to Cash Ratio | 30.94 |
| Price to Book Ratio | 9.17 |
| Dividend Yield | 0.22% |
| Shares Outstanding | 73.3M |
| Average Volume (1 week) | 576.14k |
| Average Volume (1 Month) | 398.41k |
| 52 Week Change | 1.23% |
| 52 Week High | 415.73 |
| 52 Week Low | 310.42 |
| Spread (Intraday) | 43.33 (10.81%) |
| Company Name | West Pharmaceutical Services Inc |
| Address |
530 herman o. west drive exton, pennsylvania 19341 0645 |
| Website | https://www.westpharma.com |
| Industry | fabricated rubber pds, nec (3060) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
